The 12-Month Price Target For Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) Is Now 11.
In last trading session, Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) saw 0.55 million shares changing hands with its beta currently measuring -0.54. Company’s recent per share price